Constitutive Expression KE YE, CHARLES A

Constitutive Expression KE YE, CHARLES A

Proc. Natl. Acad. Sci. USA Vol. 90, pp. 2295-2299, March 1993 Immunology Identification of the promoter region of human interleukin 1 type I receptor gene: Multiple initiation sites, high G+C content, and constitutive expression KE YE, CHARLES A. DINARELLO*, AND BURTON D. CLARK Department of Medicine, Tufts University School of Medicine and New England Medical Center, Boston, MA 02111 Communicated by Anthony S. Fauci, December 10, 1992 (receivedfor review November 10, 1992) ABSTRACT To better understand the role ofinterleukin 1 the regulation of expression of the IL-1RI gene at the (IL-1) and its receptor in disease, we have isolated a genomic molecular level, we cloned, identified, and characterized the clone of the human IL-1 type I receptor and have identified the 5' flanking region of this gene.t promoter region. There are multiple transcriptional initiation sites as demonstrated by primer extension. DNA sequence analysis shows that the promoter region contains neither a MATERIALS AND METHODS TATA nor a CAAT box; however, the 5' upstream regulatory Screening of Human Genomic Library. A human placental elements contain two AP-1-like binding sites. The internal genomic library was purchased from Clontech. This library regulatory sequences found immediately downstream to the 5' was prepared by partial Sau3A digestion and cloned into the transcriptional start site contain four Spl binding domains and BamHI site of EMBL-3 vector. Recombinant phage (106) have a high G+C content of 75%. This portion of the 5' were screened from the library through hybridization with a untranslated region of the mRNA can form stable secondary human IL-1RI cDNA probe (from position 1 to 959, a 5' Xba structure as predicted by computer modeling. Base pairs -4 to I fragment) (11). An oligonucleotide (GAAGCTGGACAC- + 10 share striking resemblance to an initiator sequence that CCCTTGGT) corresponding to the 5' untranslated region directs basal expression of certain TATA-less genes-e.g., (UTR) of the cDNA was synthesized and end-labeled as a terminal deoxynucleotidyltransferase in lymphocytes. The IL-1 probe. Southern hybridization of genomic clones with this receptor promoter directs basal expression of chloramphenicol probe verified that they contained this sequence. Genomic acetyltransferase in transiently transfected cells. Overall, the clone 29 contained sequences homologous to the human promoter of the IL-1 type I receptor gene resembles that of IL-1RI cDNA and was the longest clone obtained. It was constitutively expressed genes that have housekeeping- and/or selected and further subcloned into pGEM-3Z plasmid growth-related functions. The constitutive nature of the pro- (Promega). moter may account for this gene being expressed at low levels DNA Sequence Analysis. Different subclones of clone 29 in diverse cell types. Our rmding sheds more understanding were subjected to restriction analysis and Southern blot into the mechanisms governing the regulation of the IL-1 hybridization using IL-1RI cDNA as a probe. Hybridization- receptor in health and disease. positive fragments of appropriate size were ligated into M13mp18 and M13mpl9 bacteriophage and used for dideox- The diverse biological effects of interleukin 1 (IL-1) are ynucleotide DNA sequencing. Dideoxynucleotide DNA se- determined by the interaction of IL-1 and its receptors. quencing kits were purchased from United States Biochem- Although two IL-1 receptors have been cloned (1-3), the ical and sequencing was performed as described by the regulation of receptor synthesis remains unknown. The type manufacturer. DNA homology searches of GenBank version I receptor (IL-1RI) has a 213-amino acid cytoplasmic domain 60 were performed by using the University of Wisconsin (2) and is fully functional for signal transduction (4), whereas Genetics Computer Group (version 5) on a Vax computer. the type II receptor (IL-1RII) has only a short cytoplasmic The mRNA secondary structure was also generated by using domain of29 amino acids (3). It is not known whether the type the FOLD program that determines a secondary structure of II receptor can transduce a signal or is a nonfunctional minimum free energy for an RNA sequence on the basis of receptor. published values of stacking and loop-destabilizing energies IL-1RI has wide tissue distribution and may play a domi- (12). nant role in terms of biological function. The level of expres- Primer Extension. Primer extension was performed by sion of IL-1RI varies with different cell types. IL-1RI is using two oligonucleotide primers (30-mers) complementary overproduced in certain T-cell lines (5); however, the signif- to two sequences in the 5' UTR of the human IL-1RI mRNA; icance and mechanism of this overproduction are not clear. these sequences are ACGCACCCTCTGAAGATGGTGAC- In other cell types, the expression ofthe type I receptor is low TCCCTCC and TCGCCCTCTGAGCTGAGCCGGGTTC- (for review, see ref. 6). Regulation of IL-1RI likely plays an CGCCC (oligo 1 and oligo 2, respectively). [t-32P]ATP end- important role in controlling the effects of IL-1; increasing labeled oligonucleotide primers (3 x 105 cpm) were annealed the IL-1RI number by 1000-fold in Chinese hamster ovary to total RNA (40 ,ug) and extended with reverse transcriptase cells leads to an increase of 1000-fold in sensitivity to IL-1 (4). (Promega) according to a standard protocol (13). The reaction It is now known that a number of factors influence the level samples were resolved under denaturing conditions on a 6% ofreceptors. Among the cytokines, IL-2 and IL-4 upregulate sequencing gel alongside a set of dideoxy- IL-1RI in T-cell lines (7, 8), and platelet-derived growth polyacrylamide factor and interferony increase the receptor level in fibro- To Abbreviations: CAT, chloramphenicol acetyltransferase; UTR, un- blasts and keratinocytes, respectively (9, 10). investigate translated region; IL-1, interleukin 1; IL-1RI, IL-1 type I receptor; SRE, serum response core element. The publication costs of this article were defrayed in part by page charge *To whom reprint requests should be addressed. payment. This article must therefore be hereby marked "advertisement" tThe sequence reported in this paper has been deposited in the in accordance with 18 U.S.C. §1734 solely to indicate this fact. GenBank data base (accession no. L09701). 2295 Downloaded by guest on September 28, 2021 2296 Immunology: Ye et al. Proc. Natl. Acad. Sci. USA 90 (1993) nucleotide sequencing reactions to allow single base resolu- A Exon Exon 2 tion of the extension products. 1 51L I -j 3' Chloramphenicol Acetyltransferase (CAT) Assay. Genomic S B B fragments were inserted into plasmid pKK232-8, which con- B*-. E olE o P 2 I tains a polylinker sequence upstream of the CAT gene ohgo *.. oligo (Pharmacia). For promoter CAT construction, a 976-bp 14kb BamHI/EcoRI fragment was blunt ended with T4 polymer- ase on the EcoRI end and then the BamHI/blunt fragment was isolated and subcloned into the Sma I-BamHI site of pKK232-8 (named pKK976). The construct was transfected into the human monocytic cell line THP-1 (ATCC no. 202- I TIB). Electroporations were carried out with a Gene-Pulser E B (Bio-Rad) with 107 cells and 15 jig of plasmid DNA (purified 976 bp twice in CsCl/EtdBr gradients) at 200 V and 960 ,uF. Cells were incubated in RPMI 1640 medium containing 10% fetal B calf serum for 48 h and then lysed by three freeze-thaw TTCCCCAIGIT AGACGCACCC TCTGAAGATG GTGACTCCCT CCTGAGAAGC cycles, each consisting of a -70°C incubation (5 min) fol- Intron Exon 2 Oligo 1 lowed by 37°C for 5 min. The cell debris was removed by TGGACCCCTT GGTAAAAGAC AAGGCCTTCT CCAAGkTAAC centrifugation at 13000 x g for 15 min, and the supernatant Exon 2 Intron was assayed for CAT activity. Fifty microliters of cell lysate was added to 2 ,l of [14C]chloramphenicol (58 mCi/mmol; 1 FIG. 1. (A) Restriction map of human IL-1RI genomic clone from Ci = 37 GBq; NEN) and 20 ,ul of 4 mM acetyl coenzyme A A phage clone 29. Solid boxes, exons 1 and 2; arrows, identified (Pharmacia). The reaction mixture was incubated for 1-2 h at (solid) or possible (dotted) transcription start sites. A subcloned 976-bp EcoRI/BamHI fragment is shown below the A phage clone. 37°C and then extracted with 1 ml of ethyl acetate. The ethyl (B) Complete sequence of exon 2 (77 bp). Vertical bars indicate acetate was dried in vacuo and resuspended in 20 gl of fresh exon-intron junctions. Oligo 1 used in primer extension is under- ethyl acetate, and spotted onto a thin-layer chromatography lined. S, Sac I; E, EcoRI; B, BamHI; P, Pst I. plate. Chromatography was carried out with chloroform/ methanol (95:5). The plate was then exposed to x-ray film. products showed a single band (Fig. 2, oligo 2) 445 bases 5' upstream of the primer. This band corresponded to band 1 RESULTS from the previous extension reaction. Predicted Secondary Structure For the 5' UTR of the IL-1RI Restriction Map and Exon-Intron Organization of 5'- Gene. Unlike an earlier report (2) on the 5' UTR sequence of Specific Human IL-1RI Genomic Clone. Three overlapping IL-1RI from a T-cell library, the 5' UTR sequence of the but nonidentical genomic clones from a human placental HepG2 cell (9) contains 225 additional bases upstream of the library were obtained by using the human IL-1RI cDNA 5' as determined cDNA se- restriction fragment (Xba I digest) (11). One of the genomic translational initiation codon by clones (clone 29) was =14 kb and was the longest clone quence. These additional bases have an overall G+C content isolated; therefore, it was selected for further analysis. Based on the published cDNA sequence (2, 11), a synthetic oligo- 7 nucleotide (GAAGCTGGACCCCTTGGT) corresponding to c) the 5' UTR of the receptor was synthesized and end labeled x ,^ as a probe.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    5 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us